Novavax
NVAX
#5846
Rank
ยฃ0.79 B
Marketcap
ยฃ4.88
Share price
-0.61%
Change (1 day)
-32.94%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2025 (TTM): ยฃ0.28 Billion

According to Novavax's latest financial reports the company's current earnings are ยฃ1.02 Billion. In 2024 the company made an earning of -ยฃ0.12 Billion, an increase over its 2023 earnings that were of -ยฃ0.4 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) ยฃ0.28 B-347.98%
2024 -ยฃ0.12 Billion-70.39%
2023 -ยฃ0.4 Billion-16.59%
2022 -ยฃ0.48 Billion-62.58%
2021 -ยฃ1.27 Billion320.54%
2020 -ยฃ0.31 Billion234.22%
2019 -ยฃ89.87 Million-30.17%
2018 -ยฃ0.13 Billion1.69%
2017 -ยฃ0.13 Billion-36.44%
2016 -ยฃ0.2 Billion70.4%
2015 -ยฃ0.12 Billion89.27%
2014 -ยฃ61.75 Million59.83%
2013 -ยฃ38.63 Million81.9%
2012 -ยฃ21.24 Million50.33%
2011 -ยฃ14.13 Million
2009 -ยฃ27.88 Million8.8%
2008 -ยฃ25.63 Million18.01%
2007 -ยฃ21.72 Million18.33%
2006 -ยฃ18.36 Million168.31%
2005 -ยฃ6.84 Million-62.51%
2004 -ยฃ18.25 Million52.4%
2003 -ยฃ11.98 Million-28.21%
2002 -ยฃ16.68 Million
2000 -ยฃ9.51 Million177%
1999 -ยฃ3.44 Million-11.54%
1998 -ยฃ3.88 Million10.64%
1997 -ยฃ3.51 Million-9.62%
1996 -ยฃ3.88 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Agenus
AGEN
ยฃ15.4 M-94.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-ยฃ0.19 Billion-167.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ0.12 B-55.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-ยฃ4.94 Million-101.76%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ9.76 B 3,390.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
ยฃ8.83 B 3,060.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ12.24 B 4,278.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
-ยฃ6.06 Million-102.17%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ6.95 B 2,386.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-ยฃ0.2 Billion-168.33%๐Ÿ‡บ๐Ÿ‡ธ USA